Target (CBDY) Interest Coverage Ratio (2014 - 2026)
Target (CBDY) reported Interest Coverage Ratio of 1.08 for Q1 2026, down 275.54% year-over-year from 0.61 in Q1 2025, and down 10.02% quarter-over-quarter from 0.98 in Q4 2025.
Target (CBDY) Interest Coverage Ratio (2014 - 2026) Analysis & Trends
Target (CBDY) has 13 years of Interest Coverage Ratio data on file, last reported at 1.08 in Q1 2026.
- Interest Coverage Ratio for Q1 2026 came in at 1.08, down 275.54% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.63 (down 157.65% YoY), and the FY2025 annual result was 0.21, down 121.93% from the prior year.
- Interest Coverage Ratio fell to 1.08 in Q1 2026 per CBDY's latest filing, from 0.98 in the prior quarter.
- Over five years, Interest Coverage Ratio peaked at 11526.44 in Q1 2022 and troughed at 23125.1 in Q1 2023.
- A 5-year average of 681.99 and a median of 0.28 in 2022 frame the typical range for Interest Coverage Ratio.
- The sharpest annual moves came in 2022 and 2024: Interest Coverage Ratio jumped 746196.74% in 2022, then slumped 429.87% in 2024.
- A 5-year view of Interest Coverage Ratio shows it stood at 1.88 in 2022, then tumbled by 88.39% to 0.22 in 2023, then soared by 495.04% to 1.3 in 2024, then slumped by 175.11% to 0.98 in 2025, then retreated by 10.02% to 1.08 in 2026.
- Business Quant data shows CBDY's Interest Coverage Ratio at 1.08 in Q1 2026, 0.98 in Q4 2025, and 0.96 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | - |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 13.44 |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 108.60 |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 5.39 |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | -2.31 |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 16.72 |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | - |
| 10 | Target | - | - | 191,787.00 | -1.08 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.08 |
| Dec 31, 2025 | -0.98 |
| Sep 30, 2025 | -0.96 |
| Jun 30, 2025 | 0.52 |
| Mar 31, 2025 | 0.61 |
| Dec 31, 2024 | 1.30 |
| Sep 30, 2024 | -0.89 |
| Jun 30, 2024 | 3.30 |
| Mar 31, 2024 | 0.32 |
| Dec 31, 2023 | 0.22 |
| Sep 30, 2023 | -0.17 |
| Jun 30, 2023 | -0.30 |
| Mar 31, 2023 | -23,125.10 |
| Dec 31, 2022 | 1.88 |
| Sep 30, 2022 | 0.71 |
| Jun 30, 2022 | 0.28 |
| Mar 31, 2022 | 11,526.44 |
| Sep 30, 2021 | -0.25 |
| Jun 30, 2021 | -1.61 |
| Mar 31, 2021 | -1.54 |